非腫瘍遺伝的依存症とがん細胞のストレス現象型

Nicole L Solimini¹, Ji Luo, Stephen J Elledge

¹Howard Hughes Medical Institute and Department of Genetics, Center for Genetics and Genomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Cell

|September 25, 2007

まとめ

熱ショック因子1 (HSF1) は,がんの発症と成長に不可欠です. HSF1を標的にすることは,がん薬の開発のための有望な新しい戦略であり,様々な悪性腫瘍に対する潜在的な治療法を提供します.

科学分野:

分子生物学は分子生物学である.
細胞のストレス反応は,
腫瘍学腫瘍学

背景:

熱ショック因子1 (HSF1) は,タンパク質毒性ストレスに対する細胞の反応を調節する重要な転写因子です.
熱ショック反応は,様々なストレス要因に対する基本的な細胞防衛機構です.
HSF1のがんにおける役割,特に腫瘍の発症と進行における役割は,現在活発に研究されている分野である.

研究の目的:

腫瘍発生における熱ショック因子1 (HSF1) の役割を調査する.
異なるがんモデルにおける腫瘍の発症および維持にHSF1が不可欠であるかどうかを判断する.
HSF1を潜在的ながん薬標的として評価する.

主な方法:

HSF1.1の影響を評価するために,さまざまながんモデルを使用しました.
腫瘍発症にHSF1の必要性を研究した.
腫瘍の維持のためにHSF1の必要性を調査した.

主要な成果:

HSF1は,腫瘍発生の強力な修正剤として特定されました.
HSF1は,複数のがんモデルの腫瘍の発症に不可欠です.
HSF1は,確立した腫瘍の維持と進行にも必要である.

結論:

HSF1は,がんの発生と進行において重要な役割を果たします.
これらの発見は,HSF1をがん治療の重要なノンコゲン標的として強調しています.
HSF1をターゲットにすることで,さまざまながんの治療に新たな治療戦略が提供される可能性があります.

さらに関連する動画

05:49

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle

Published on: April 27, 2021

09:06

Measurement of the Compressibility of Cell and Nucleus Based on Acoustofluidic Microdevice

Published on: July 14, 2022

関連する概念動画

02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...